(CD) Crohn's disease
Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review
9
Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers
9
Mean platelet volume: a controversial marker of disease activity in Crohn’s disease
7
Successful treatment of rectovaginal fistula and rectal stenosis due to perianal Crohn’s disease by dual-port laparoscopic abdominoperineal resection: a report of two cases
6
Co inheritance of variants/mutations in Malaysian patients with Crohn s disease
7
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
15
Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
9
A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease
5
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with active Crohn’s disease
5
Mitochondrial neurogastrointestinal encephalopathy: a clinicopathological mimic of Crohn’s disease
5
Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn’s disease: study protocol for a randomised controlled trial
9
Neonatal Crohn’s disease with Oral ulcer as the first symptom caused by a compound heterozygote mutation in IL-10RA: a case report
10
Genetic variants associated with Crohn's disease
8
Crohn’s disease in women
8
Infliximab to treat Crohn’s disease: an update
12
Measuring disease activity in Crohn's disease: what is currently available to the clinician
11
Infliximab therapy in pediatric Crohn’s disease: a review
7
Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial
12
Managing refractory Crohn's disease: challenges and solutions
10
Difficult-to-treat-pediatric Crohn's disease: focus on adalimumab
8